Home/REMD Biotherapeutics/Not specified on site
NS

Not specified on site

Co-Founder (Former Amgen Scientist)

REMD Biotherapeutics

Roles

Co-Founder (Former Amgen Scientist)atREMD Biotherapeutics
Co-Founder (Former Amgen Scientist)atREMD Biotherapeutics

REMD Biotherapeutics Pipeline

DrugIndicationPhase
REMD-477 (Volagidemab)Type 1 DiabetesPhase 3 (planned)
REMD-477 (Volagidemab) + GLP-1Obesity / Type 2 DiabetesPhase 2 (planned)
BC008-1A (Bispecific)Not specified (Oncology/Immunology)Phase 1